Increased microvascular permeability induced by eosinophil proteins.
Minnicozzi
M
M
Schering-Plough Research Institute, Kenilworth, NY, USA.
Gleich
G J
GJ
Durán
W N
WN
Egan
R W
RW
D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000494:pharmacology; D001798:Blood Proteins / Q000494:pharmacology*; D002199:Capillary Permeability / Q000187:drug effects*; D002610:Cheek; D006224:Cricetinae; D047091:Eosinophil Granule Proteins; D047209:Eosinophil Peroxidase; D047208:Eosinophil-Derived Neurotoxin; D009061:Mouth Mucosa; D019331:NG-Nitroarginine Methyl Ester; D009498:Neurotoxins / Q000494:pharmacology*; D010544:Peroxidases / Q000494:pharmacology*; D012260:Ribonucleases
D001798:Blood Proteins; D047091:Eosinophil Granule Proteins; D009498:Neurotoxins; D001120:Arginine; D047209:Eosinophil Peroxidase; D010544:Peroxidases; D047208:Eosinophil-Derived Neurotoxin; D012260:Ribonucleases; D019331:NG-Nitroarginine Methyl Ester